Matches in Wikidata for { <http://www.wikidata.org/entity/Q57279955> ?p ?o ?g. }
- Q57279955 description "2018 թվականի հոկտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q57279955 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q57279955 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57279955 description "scientific article published on 11 October 2018" @default.
- Q57279955 description "wetenschappelijk artikel" @default.
- Q57279955 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57279955 name "Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage" @default.
- Q57279955 name "Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage" @default.
- Q57279955 type Item @default.
- Q57279955 label "Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage" @default.
- Q57279955 label "Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage" @default.
- Q57279955 prefLabel "Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage" @default.
- Q57279955 prefLabel "Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage" @default.
- Q57279955 P1433 Q57279955-5BC50FE6-540C-47F0-9550-2096D2870E53 @default.
- Q57279955 P1476 Q57279955-E3CA3BAB-EDBD-4B9C-929C-5C27AC02395B @default.
- Q57279955 P2093 Q57279955-3F164F20-94D9-438B-BB14-E80E9C5545EF @default.
- Q57279955 P2093 Q57279955-71670129-7017-4728-B278-05FDC758ABF9 @default.
- Q57279955 P2093 Q57279955-7A70B40D-AAF7-4F34-A4D2-98CAAEC4CEC8 @default.
- Q57279955 P2860 Q57279955-137942E8-ADE7-4595-9FF1-D2D2F612C0F1 @default.
- Q57279955 P2860 Q57279955-26CEDA6B-ABE0-400A-A543-32B3F50C4807 @default.
- Q57279955 P2860 Q57279955-3B6999BE-0509-4296-9E8F-2F944B2CA430 @default.
- Q57279955 P2860 Q57279955-47DFDB4A-706B-46DE-B25C-49037D5D239B @default.
- Q57279955 P2860 Q57279955-64D759CF-765B-48F4-98E4-210B95516408 @default.
- Q57279955 P2860 Q57279955-69419546-E7E0-4E89-9C0E-B2BEEB089536 @default.
- Q57279955 P2860 Q57279955-7F1D894A-F5B1-4EA6-B54C-6534F3D98173 @default.
- Q57279955 P2860 Q57279955-82BCE219-D0B4-4DC2-8C03-10DD0DFB02D7 @default.
- Q57279955 P2860 Q57279955-8F7E49DC-DC78-4F9F-BEB2-3A8509FD1A2B @default.
- Q57279955 P2860 Q57279955-96A88299-67A2-4CC6-8185-A2AC8C3DC328 @default.
- Q57279955 P2860 Q57279955-96FE2406-0FD2-4011-BEA2-9929DA9F729F @default.
- Q57279955 P2860 Q57279955-9728A680-25CA-4D9B-A0FD-9F82EF940774 @default.
- Q57279955 P2860 Q57279955-B86C2A64-4084-4B17-B74C-5D47A0A9668F @default.
- Q57279955 P2860 Q57279955-C233F6FB-DD9E-4D17-8E7B-ECF387206420 @default.
- Q57279955 P2860 Q57279955-C78C12AB-1EF3-493B-9B58-406C0B82D6DD @default.
- Q57279955 P2860 Q57279955-C96FE30E-1BB0-4B8E-99FD-D37303CC8D1E @default.
- Q57279955 P2860 Q57279955-D39B801C-F311-476A-B0F7-F6AC6E71F748 @default.
- Q57279955 P2860 Q57279955-D65F34DB-2605-46F1-B50B-14A871F60F1E @default.
- Q57279955 P2860 Q57279955-E538431F-70FE-41C6-A6FD-4636CA2234FC @default.
- Q57279955 P2860 Q57279955-F49488A0-EBFE-498F-85DB-D4F314807ABC @default.
- Q57279955 P2860 Q57279955-F736F0CD-CB62-4F4B-B606-10A2DAF9A5F7 @default.
- Q57279955 P304 Q57279955-B9281B10-0A93-45D5-8FA8-F63B21190A96 @default.
- Q57279955 P31 Q57279955-6F3DBA2F-4CD4-4D71-848E-B081AED285D1 @default.
- Q57279955 P356 Q57279955-E1BA9F4F-A5ED-4338-A1F4-9F918C7DECD0 @default.
- Q57279955 P407 Q57279955-D6FBE9E4-2C38-4834-9841-05425333EC14 @default.
- Q57279955 P433 Q57279955-C1168ECF-B8AD-4684-A089-E4728C2D59BE @default.
- Q57279955 P478 Q57279955-4F880EA9-47CE-4610-8162-BE0B2299F624 @default.
- Q57279955 P50 Q57279955-17C67146-D0CC-410A-AB82-F1E7E6929BC1 @default.
- Q57279955 P50 Q57279955-222416B1-A1F6-4CDC-8608-B2D80F41B425 @default.
- Q57279955 P50 Q57279955-4A3B35B8-8AF8-40F4-8C10-02DBF9F22359 @default.
- Q57279955 P50 Q57279955-58E08271-05DA-4ABD-92DC-57A77666573D @default.
- Q57279955 P50 Q57279955-72C67187-BD57-4E78-92D0-35BF0B1E1B7C @default.
- Q57279955 P50 Q57279955-72F7CF33-6654-4E7A-9604-F65B3A14A61C @default.
- Q57279955 P50 Q57279955-7B5B968D-A819-44D1-BD1B-5DF3ADF835C7 @default.
- Q57279955 P50 Q57279955-87A91CE6-92F8-4511-9331-50CFE982BB2B @default.
- Q57279955 P50 Q57279955-8F35F0F1-B086-4165-8A60-FE774A3FA1F2 @default.
- Q57279955 P50 Q57279955-97D72BC2-14DA-4FD3-90B3-F5E12E0E76CA @default.
- Q57279955 P50 Q57279955-B6A85B31-0F89-4AE4-BCED-8EFBD74FB035 @default.
- Q57279955 P50 Q57279955-BC0311D1-2116-49DF-A847-A20B35925F10 @default.
- Q57279955 P50 Q57279955-C1A97596-A849-46D2-8850-5A38DABBDCAE @default.
- Q57279955 P50 Q57279955-DC2CE1C7-1BE2-4027-A6C2-8CA5F37F98A4 @default.
- Q57279955 P50 Q57279955-E1908680-0F34-42D9-A6D6-C65FC6797BC2 @default.
- Q57279955 P50 Q57279955-E5D0D956-7B10-4DF5-954D-07D0AD95DD09 @default.
- Q57279955 P50 Q57279955-EB1B5932-AB0D-4A3B-8AD6-2C290215BCFB @default.
- Q57279955 P577 Q57279955-F6ABC852-9B44-4B5B-84AA-70D15304C7AE @default.
- Q57279955 P698 Q57279955-941106A6-B1F1-4990-A5A3-4492AC4EE526 @default.
- Q57279955 P921 Q57279955-433807B9-A269-46B4-A70D-D531C984A768 @default.
- Q57279955 P921 Q57279955-5788D9D4-E2F3-4AF2-B0C8-57F53B44B383 @default.
- Q57279955 P932 Q57279955-CD4CA91B-7576-4DF9-AAD5-FB12FF5CBACA @default.
- Q57279955 P356 CNCR.31720 @default.
- Q57279955 P698 30307611 @default.
- Q57279955 P1433 Q326041 @default.
- Q57279955 P1476 "Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage" @default.
- Q57279955 P2093 "Farhad Ravandi" @default.
- Q57279955 P2093 "Kathryn Montalbano" @default.
- Q57279955 P2093 "Nitin Jain" @default.
- Q57279955 P2860 Q33476068 @default.
- Q57279955 P2860 Q33822004 @default.
- Q57279955 P2860 Q34033852 @default.
- Q57279955 P2860 Q36751420 @default.
- Q57279955 P2860 Q36781942 @default.
- Q57279955 P2860 Q37039074 @default.
- Q57279955 P2860 Q38371346 @default.
- Q57279955 P2860 Q38428357 @default.
- Q57279955 P2860 Q40295439 @default.
- Q57279955 P2860 Q40312849 @default.
- Q57279955 P2860 Q40591760 @default.
- Q57279955 P2860 Q40705613 @default.
- Q57279955 P2860 Q41962966 @default.
- Q57279955 P2860 Q42223690 @default.
- Q57279955 P2860 Q43889424 @default.
- Q57279955 P2860 Q44612967 @default.
- Q57279955 P2860 Q47596252 @default.
- Q57279955 P2860 Q49029195 @default.
- Q57279955 P2860 Q49553520 @default.
- Q57279955 P2860 Q49905062 @default.
- Q57279955 P2860 Q80853383 @default.
- Q57279955 P304 "4044-4055" @default.
- Q57279955 P31 Q13442814 @default.
- Q57279955 P356 "10.1002/CNCR.31720" @default.
- Q57279955 P407 Q1860 @default.
- Q57279955 P433 "20" @default.